Arriva Pharmaceuticals Adds $6M

Alameda- and Amsterdam-based Arriva Pharmaceuticals said Thursday that the firm has raised $6M in a funding round. The funding came from Nordic Biotech II K/S and MPM BioVentures. The round brings the company's total raised to $81M. Arriva Pharmaceuticals is developing anti-inflammatory treatments for respiratory disease. More information »